No, well at least for me it didn't. First, transdermal absorption is quite variable, especially in humans. Even in lab rats, which are much more similar to one another than humans are, significant variance exists between individuals in absorption rates, meaning that is difficult to predetermine dosage for a given time interval. Also, the transdermal process is much less quick than alveolar transfer, meaning that the user really has no control over the dosage they are getting at any one snapshot time interval. Inhalation remains the most efficient method of delivering a compound directly into the atrial bloodstream. It is much more quick than even intravenous injection, because when substances are absorbed in conjunction with respired air, they directly enter the arterial blood supply, and they bypass the whole process that moves venous blood through the heart to get it to the lungs for oxygenation. Thus, the vaper/smoker has much more specific control over the dose of the compound. For my particular requirements for dosing myself with nicotine (i.e., which I do at a relatively high concentration per puff/drag), it is important that I am able to respond to my nicotine load in real time. If I start feeling nicotine effects after a puff/drag, I can, simply, not take another puff/drag until the effect subsides. I wouldn't have such control with a patch. By the time I recognized, for example, that my nicotine burden was too high, I wouldn't have any means of controlling it, which could lead to an unpleasant experience with nicotine intoxication. I would never deliver any drug transdermally, unless I had worked out the kinetics in conjunction with a solvent such as DMSO that would give me better dosing capability.